QUEST LABORATORIES
|
QUEST LABORATORIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 8.28 | 8.46 | 46.77 | 38.05 | 6.07 |
| CEPS(Rs) | 8.67 | 8.93 | 5.19 | 4.23 | 0.97 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 49.92 | 24.01 | 139.97 | 92.64 | 54.58 |
| Tax Rate(%) | 27.39 | 30.13 | 27.74 | 28.82 | 17.04 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 15.37 | 18.85 | 12.73 | 10.87 | 4.67 |
| EBIT Margin(%) | 18.84 | 18.44 | 12.20 | 10.19 | 3.61 |
| Pre Tax Margin(%) | 17.97 | 17.50 | 11.33 | 9.69 | 2.60 |
| PAT Margin (%) | 13.05 | 12.23 | 8.18 | 6.90 | 2.16 |
| Cash Profit Margin (%) | 13.66 | 12.91 | 9.08 | 7.67 | 3.45 |
| Performance Ratios | |||||
| ROA(%) | 14.89 | 18.78 | 12.34 | 15.43 | 3.56 |
| ROE(%) | 24.56 | 46.13 | 40.21 | 51.69 | 11.12 |
| ROCE(%) | 26.87 | 57.51 | 46.54 | 55.00 | 12.28 |
| Asset Turnover(x) | 1.14 | 1.54 | 1.51 | 2.24 | 1.65 |
| Sales/Fixed Asset(x) | 6.89 | 6.10 | 5.33 | 6.54 | 3.73 |
| Working Capital/Sales(x) | 1.49 | 4.11 | 13.31 | 15.27 | 26.93 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.15 | 0.16 | 0.19 | 0.15 | 0.27 |
| Receivable days | 95.62 | 98.10 | 124.35 | 95.77 | 110.05 |
| Inventory Days | 65.81 | 60.30 | 36.25 | 5.88 | 9.95 |
| Payable days | 60.76 | 157.99 | 181.85 | 102.60 | 118.86 |
| Valuation Parameters | |||||
| PER(x) | 12.38 | - | - | - | - |
| PCE(x) | 11.82 | - | - | - | - |
| Price/Book(x) | 2.05 | - | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.90 | 0.20 | 0.08 | 0.04 | 0.12 |
| EV/Core EBITDA(x) | 9.79 | 1.07 | 0.63 | 0.40 | 2.48 |
| EV/EBIT(x) | 10.11 | 1.11 | 0.67 | 0.43 | 3.38 |
| EV/CE(x) | 1.77 | 0.50 | 0.26 | 0.20 | 0.41 |
| M Cap / Sales | 1.61 | - | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 25.92 | 33.94 | 3.63 | 95.91 | - |
| Core EBITDA Growth(%) | 28.07 | 95.70 | 23.70 | 337.71 | - |
| EBIT Growth(%) | 28.67 | 102.46 | 24.03 | 452.92 | - |
| PAT Growth(%) | 34.40 | 100.08 | 22.90 | 526.72 | - |
| EPS Growth(%) | -2.09 | -81.92 | 22.90 | 526.72 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.37 | 0.18 | 0.27 | 0.31 | 0.52 |
| Current Ratio(x) | 2.88 | 1.67 | 1.16 | 1.17 | 1.10 |
| Quick Ratio(x) | 2.30 | 1.13 | 0.78 | 1.12 | 1.03 |
| Interest Cover(x) | 21.63 | 19.54 | 13.97 | 20.45 | 3.57 |
| Total Debt/Mcap(x) | 0.18 | - | - | - | - |
Compare Financial Ratios of peers of QUEST LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| QUEST LABORATORIES | ₹146.0 Cr | -6.3% | -10.1% | 2.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
QUEST LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| QUEST LABORATORIES | -6.3% |
-10.1% |
2.6% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses